Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 28, 2022, 4:21 p.m.

/zigman2/quotes/200043077/composite

$

33.00

Change

+0.63 +1.95%

Volume

Volume 16,823

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Today's close

$ 31.45

$ 32.37

Change

+0.92 +2.93%

Day low

Day high

$30.51

$32.39

Open

52 week low

52 week high

$30.25

$79.70

Open

Annual Financials for Denali Therapeutics Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Net Income before Extraordinaries (86.65M)(88.19M)(36.24M)(197.61M)71.14M
Depreciation, Depletion & Amortization 1.47M3.08M7.42M7.99M6.17M
Depreciation and Depletion 1.47M3.08M7.42M7.99M-
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 8.54M5.16M16.05M33.87M50.44M
Funds from Operations (76.65M)(79.94M)(12.78M)(155.75M)127.75M
Extraordinaries -----
Changes in Working Capital 4.74M3.31M62.89M2.92M(9.02M)
Receivables -----
Accounts Payable 161,000207,000(526,000)1.03M(1.62M)
Other Assets/Liabilities (781,000)(480,000)50.87M389,000(29.5M)
Net Operating Cash Flow (71.91M)(76.64M)50.12M(152.83M)118.73M

Investing Activities

20162017201820192020 5-year trend
Capital Expenditures (6.13M)(2.88M)(3.39M)(17.92M)(3.1M)
Capital Expenditures (Fixed Assets) (6.13M)(2.88M)(3.39M)(17.92M)(3.1M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments (212.87M)(38.29M)(284.03M)165.63M(620.11M)
Purchase of Investments (226.87M)(179.79M)(557.93M)(369.7M)(1.29B)
Sale/Maturity of Investments 14M141.5M273.9M535.33M665.36M
Other Uses -----
Other Sources -----
Net Investing Cash Flow (219M)(41.17M)(287.42M)147.71M(623.21M)

Financing Activities

20162017201820192020 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 300.48M296.32M97.02M6.19M634.75M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 300.48M296.32M97.02M6.19M634.75M
Proceeds from Stock Options 300.37M295.59M93.02M-614.09M
Other Proceeds from Sale of Stock 111,000733,0004M6.19M20.66M
Issuance/Reduction of Debt, Net ---1.25M297.42M
Change in Current Debt ---1.25M297.42M
Change in Long-Term Debt -----
Issuance of Long-Term Debt -----
Reduction in Long-Term Debt -----
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 300.48M296.32M97.02M7.44M932.17M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash 9.56M178.52M(140.29M)2.33M427.7M
Free Cash Flow (78.04M)(79.51M)46.72M(170.75M)115.64M
Trending Tickers
  • /zigman2/quotes/200030751/composite CLSK-1.06%
  • /zigman2/quotes/228559245/composite ADGI-78.81%
  • /zigman2/quotes/216531076/composite ESSC-26.63%
  • /zigman2/quotes/211617595/composite BYND+9.29%
  • /zigman2/quotes/205021014/composite RUN-15.70%
X
Powered by StockTwits
Link to MarketWatch's Slice.